Large vessel (Takayasu's) arteritis in a patient with myelodysplastic syndrome: Is there a common pathogenesis?

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 1, 2011, Pages 60-63

  Cohen, Matan J ^a   Shyman, Anat ^a   Klein, Martine ^a   Ben Yehuda, Aryeh ^a   Rubinow, Alan ^a   Or, Reuven ^a   Goldschmidt, Neta ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

autoimmunity; Large vessel vasculitis; T cells; Takayasu's arteritis

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BUSULFAN; CYTARABINE; DAUNORUBICIN; FLUDARABINE; FLUORODEOXYGLUCOSE F 18; METHOTREXATE; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADD ON THERAPY; ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; AORTA ARCH SYNDROME; ARTICLE; BLOOD VESSEL BIOPSY; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DEATH; DRUG DOSE REDUCTION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INSOMNIA; MALE; MYELODYSPLASTIC SYNDROME; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; THROMBOCYTOSIS; TREATMENT RESPONSE;

EID: 79953675716     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2011.n.008     Document Type: Article

References (26)

1. Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med 2009; 361:1872-85.
2. Giannouli S, Voulgarelis M, Zintzaras E, et al. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford) 2004; 43:626-32. (Pubitemid 38628195)
3. Hamidou MA, Boumalassa A, Larroche C, et al. Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. Semin Arthritis Rheum 2001; 31:119-26. (Pubitemid 32988971)
4. Lopez FF, Vaidyan PB, Mega AE, et al. Aortitis as a manifestation of myelodysplastic syndrome. Postgrad Med J 2001; 77:116-8. (Pubitemid 32120984)
5. Steurer M, Fritsche G, Tzankov A, et al. Large-vessel arteritis and myelodysplastic syndrome: report of two cases. Eur J Haematol 2004; 73:128-33. (Pubitemid 38980113)
6. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89:2079-88. (Pubitemid 27132124)
7. Barrett AJ, Sloand E. Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica 2009; 94:449-51.
8. Voulgarelis M, Giannouli S, Ritis K, et al. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest 2004; 34:690-700. (Pubitemid 39423027)
9. Rajapaksa R, Ginzton N, Rott LS, et al. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996; 88:4275-87. (Pubitemid 26399175)
10. Okamoto T, Okada M, Mori A, et al. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 1997; 66:345-51. (Pubitemid 27495992)
11. Melenhorst JJ, Eniafe R, Follmann D, et al. Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol 2002; 119:97-105. (Pubitemid 35176503)
12. Killick SB, Mufti G, Cavenagh JD, et al. A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia. Br J Haematol 2003; 120:679-84. (Pubitemid 36255870)
13. Hamblin TJ. Myelodysplasia. Br J Hosp Med 1987; 38:558-61. (Pubitemid 18000077)
14. Enright H, Jacob HS, Vercellotti G, et al. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995; 91:403-8.
15. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002; 43:2083-92. (Pubitemid 35174719)
16. Billstrom R, Johansson H, Johansson B, et al. Immune-mediated complications in patients with myelodysplastic syndromes-clinical and cytogenetic features. Eur J Haematol 1995; 55:42-8.
17. Seko Y, Takahashi N, Tada Y, et al. Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 2000; 75(suppl 1):S77-83; discussion S85-77.
18. Takeda N, Takahashi T, Seko Y, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med 2005; 44:256-60. (Pubitemid 40575909)
19. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009; 10:223-32.
20. Cutler CS, Lee SJ, Greenberg P, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004; 104:579-85. (Pubitemid 38900045)
21. Arnaud L, Haroche J, Malek Z, et al. Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 2009; 60:1193-200.
22. Walter MA, Melzer RA, Schindler C, et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005; 32:674-81. (Pubitemid 40897490)
23. Webb M, Chambers A, A AL-N, et al. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004; 31:627-34. (Pubitemid 38647900)
24. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 2004; 63:995-1000. (Pubitemid 38961927)
25. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33:1129-34. (Pubitemid 20273298)
26. Neumann T, Oelzner P, Freesmeyer M, et al. Images in cardiovascular medicine. Diagnosis of large-vessel vasculitis by [18F] fluorodeoxyglucose- positron emission tomography. Circulation 2009; 119:338-9.